INVASIVE DUCTAL BREAST CARCINOMA
Clinical trials for INVASIVE DUCTAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INVASIVE DUCTAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for INVASIVE DUCTAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a week of radiation be enough? new trial tests Ultra-Short breast cancer treatment
Disease control Recruiting nowThis study is for women aged 45 and older with early-stage breast cancer or DCIS who have had a lumpectomy. It tests whether a very short course of targeted radiation (over a few days instead of weeks) is safe and works as well as standard radiation. The main goal is to see if th…
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New radiation technique could boost immune attack on tumors
Symptom relief Recruiting nowThis study compares a new radiation technique called lattice radiation therapy (LRT) to standard stereotactic body radiation therapy (SBRT) for people with solid tumors that have spread to soft tissues. The goal is to see if LRT shrinks tumors better and helps immune cells attack…
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 16, 2026 22:30 UTC